All Stories

  1. PENS Position Statement on Bullying Prevention
  2. Congenital hypogonadotropic hypogonadism and constitutional delay of growth and puberty have distinct genetic architectures
  3. International practice settings, interventions and outcomes of nurse practitioners in geriatric care: A scoping review
  4. GENETICS IN ENDOCRINOLOGY: Genetic counseling for congenital hypogonadotropic hypogonadism and Kallmann syndrome: new challenges in the era of oligogenism and next-generation sequencing
  5. Patient Perspectives on Nurse-led Consultations Within a Pilot Structured Transition Program for Young Adults Moving From an Academic Tertiary Setting to Community-based Type 1 Diabetes Care
  6. DCC/NTN1 complex mutations in patients with congenital hypogonadotropic hypogonadism impair GnRH neuron development
  7. Meta-analysis of the effectiveness of nursing discharge planning interventions for older inpatients discharged home
  8. Evaluating CHARGE syndrome in congenital hypogonadotropic hypogonadism patients harboring CHD7 variants
  9. Feasibility of advanced practice nursing in lung cancer consultations during early treatment: A phase II study
  10. KLB , encoding β‐Klotho, is mutated in patients with congenital hypogonadotropic hypogonadism
  11. Beyond hormone replacement: quality of life in women with congenital hypogonadotropic hypogonadism
  12. Clinical practice overlap and seamless care - links between hypogonadism, the metabolic syndrome and type 2 diabetes
  13. β-Klotho deficiency protects against obesity through a crosstalk between liver, microbiota, and brown adipose tissue
  14. Genetic testing facilitates prepubertal diagnosis of congenital hypogonadotropic hypogonadism
  15. Developing and evaluating rare disease educational materials co-created by expert clinicians and patients: the paradigm of congenital hypogonadotropic hypogonadism
  16. Adherence to treatment
  17. Society for Endocrinology UK guidance on the evaluation of suspected disorders of sexual development: emphasizing the opportunity to predict adolescent pubertal failure through a neonatal diagnosis of absent minipuberty
  18. Male infertility
  19. Effectiveness of nursing discharge planning interventions on health-related outcomes in discharged elderly inpatients
  20. Multidisciplinary management of diabetic kidney disease
  21. Unmet health and information needs of women with hypogonadotropic hypogonadism
  22. MANAGEMENT OF ENDOCRINE DISEASE: Reversible hypogonadotropic hypogonadism: Table 1
  23. Expert consensus document: European Consensus Statement on congenital hypogonadotropic hypogonadism—pathogenesis, diagnosis and treatment
  24. Research topic: identifying the needs of patients with Congenital Hypogonadotrophic Hypogonadism, implications for nursing practice
  25. Psychosexual Development in Men with Congenital Hypogonadotropic Hypogonadism on Long-Term Treatment: A Mixed Methods Study
  26. Natural History of Growth Hormone Deficiency in a Pediatric Cohort
  27. TRANSITION IN ENDOCRINOLOGY: Hypogonadism in adolescence
  28. Comment on reversal of hypogonadotropic hypogonadism in a Chinese cohort
  29. Gonadotrophin replacement for induction of fertility in hypogonadal men
  30. Congenital hypogonadotropic hypogonadism with split hand/foot malformation: a clinical entity with a high frequency of FGFR1 mutations
  31. Skeletal Muscle Mitochondria in the Elderly: Effects of Physical Fitness and Exercise Training
  32. Hormonal control of spermatogenesis in men: Therapeutic aspects in hypogonadotropic hypogonadism
  33. Adherence to treatment for chronic hypogonadism: the role of illness perceptions and depressive symptoms
  34. Reversal and Relapse of Hypogonadotropic Hypogonadism: Resilience and Fragility of the Reproductive Neuroendocrine System
  35. Identifying the unmet health needs of patients with congenital hypogonadotropic hypogonadism using a web-based needs assessment: implications for online interventions and peer-to-peer support
  36. Testosterone restoration using enclomiphene citrate in men with secondary hypogonadism: a pharmacodynamic and pharmacokinetic study
  37. Trial of Recombinant Follicle-Stimulating Hormone Pretreatment for GnRH-Induced Fertility in Patients with Congenital Hypogonadotropic Hypogonadism
  38. Ataxia, Dementia, and Hypogonadotropism Caused by Disordered Ubiquitination
  39. Prioritizing Genetic Testing in Patients With Kallmann Syndrome Using Clinical Phenotypes
  40. Mutations in FGF17, IL17RD, DUSP6, SPRY4, and FLRT3 Are Identified in Individuals with Congenital Hypogonadotropic Hypogonadism
  41. Comparative functional analysis of two fibroblast growth factor receptor 1 (FGFR1) mutations affecting the same residue (R254W and R254Q) in isolated hypogonadotropic hypogonadism (IHH)
  42. Abrupt decrease in serum testosterone levels after an oral glucose load in men: implications for screening for hypogonadism
  43. An ancient founder mutation in PROKR2 impairs human reproduction
  44. The lack of effect of insulin on luteinizing hormone pulsatility in healthy male volunteers provides evidence of a sexual dimorphism in the metabolic regulation of reproductive hormones
  45. Genetic Overlap in Kallmann Syndrome, Combined Pituitary Hormone Deficiency, and Septo-Optic Dysplasia
  46. GnRH-Deficient Phenotypes in Humans and Mice with Heterozygous Variants inKISS1/Kiss1
  47. Role of fibroblast growth factor (FGF) signaling in the neuroendocrine control of human reproduction
  48. Genetic basis and variable phenotypic expression of Kallmann syndrome: towards a unifying theory
  49. The Role of the Prokineticin 2 Pathway in Human Reproduction: Evidence from the Study of Human and Murine Gene Mutations
  50. Expanding the Phenotype and Genotype of Female GnRH Deficiency
  51. The Long-Term Clinical Follow-Up and Natural History of Men with Adult-Onset Idiopathic Hypogonadotropic Hypogonadism
  52. Oligogenic basis of isolated gonadotropin-releasing hormone deficiency
  53. TAC3/TACR3Mutations Reveal Preferential Activation of Gonadotropin-Releasing Hormone Release by Neurokinin B in Neonatal Life Followed by Reversal in Adulthood
  54. Congenital Idiopathic Hypogonadotropic Hypogonadism: Evidence of Defects in the Hypothalamus, Pituitary, and Testes
  55. Impact of Acute Biochemical Castration on Insulin Sensitivity in Healthy Adult Men
  56. Human GnRH Deficiency: A Unique Disease Model to Unravel the Ontogeny of GnRH Neurons
  57. Frequency of Impaired Fibroblast Growth Factor Receptor 1 Signaling as a Cause of Normosmic Idiopathic Hypogonadotropic Hypogonadism
  58. Frequency of Impaired Fibroblast Growth Factor Receptor 1 Signaling as a Cause of Normosmic Idiopathic Hypogonadotropic Hypogonadism
  59. Impaired Fibroblast Growth Factor Receptor 1 Signaling as a Cause of Normosmic Idiopathic Hypogonadotropic Hypogonadism
  60. Role of Seminiferous Tubular Development in Determining the FSH versus LH Responsiveness to GnRH in Early Sexual Maturation
  61. Mutations inProkineticin 2andProkineticin receptor 2genes in Human Gonadotrophin-Releasing Hormone Deficiency: Molecular Genetics and Clinical Spectrum
  62. Decreased FGF8 signaling causes deficiency of gonadotropin-releasing hormone in humans and mice
  63. The Relative Role of Gonadal Sex Steroids and Gonadotropin-Releasing Hormone Pulse Frequency in the Regulation of Follicle-Stimulating Hormone Secretion in Men
  64. Relative Roles of Inhibin B and Sex Steroids in the Negative Feedback Regulation of Follicle-Stimulating Hormone in Men across the Full Spectrum of Seminiferous Epithelium Function
  65. Inhibition of Luteinizing Hormone Secretion by Testosterone in Men Requires Aromatization for Its Pituitary But Not Its Hypothalamic Effects: Evidence from the Tandem Study of Normal and Gonadotropin-Releasing Hormone-Deficient Men
  66. Acute Sex Steroid Withdrawal Reduces Insulin Sensitivity in Healthy Men with Idiopathic Hypogonadotropic Hypogonadism
  67. Reversal of Idiopathic Hypogonadotropic Hypogonadism
  68. Digenic mutations account for variable phenotypes in idiopathic hypogonadotropic hypogonadism
  69. Coding sequence analysis of GNRHR and GPR54 in patients with congenital and adult-onset forms of hypogonadotropic hypogonadism
  70. Mutations in fibroblast growth factor receptor 1 cause Kallmann syndrome with a wide spectrum of reproductive phenotypes
  71. Mutations in fibroblast growth factor receptor 1 cause both Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism
  72. Testis morphology in patients with idiopathic hypogonadotropic hypogonadism
  73. Relationship Between Testosterone Levels, Insulin Sensitivity, and Mitochondrial Function in Men
  74. Increasing Insulin Resistance Is Associated with a Decrease in Leydig Cell Testosterone Secretion in Men
  75. Reversible Kallmann Syndrome, Delayed Puberty, and Isolated Anosmia Occurring in a Single Family with a Mutation in the Fibroblast Growth Factor Receptor 1 Gene
  76. Acute Stress Masking the Biochemical Phenotype of Partial Androgen Insensitivity Syndrome in a Patient with a Novel Mutation in the Androgen Receptor
  77. Predictors of Outcome of Long-Term GnRH Therapy in Men with Idiopathic Hypogonadotropic Hypogonadism